Purpose
|
Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease. It is a member of the class of nitrocatechols. When administered concomittantly with levodopa and a decarboxylase inhibitor (e.g., carbidopa), increased and more sustained plasma levodopa concentrations are reached as compared to the administration of levodopa and a decarboxylase inhibitor.
|
Characteristics
|
Source of Compound: synthetic Target: Histone Methyltransferase inhibitor Receptor: COMT Status: USP
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C14H15N3O5
|
Solubility
|
DMSO 61 mg/mL,Ethanol 2 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |